DTx Pharma, Inc.
DTx Pharma, Inc., a pioneering biopharmaceutical company headquartered in the United States, is at the forefront of developing innovative therapies for patients with serious diseases. Founded in [year], DTx Pharma focuses on the discovery and advancement of novel drug candidates that leverage its proprietary platform for targeted delivery of therapeutics.
With a strong emphasis on precision medicine, the company is dedicated to addressing unmet medical needs in areas such as oncology and rare diseases. DTx Pharma's unique approach combines cutting-edge technology with a commitment to improving patient outcomes, positioning it as a leader in the biopharmaceutical industry. Notable achievements include [key milestones], which underscore its rapid growth and market presence. As DTx Pharma continues to expand its operational reach, it remains committed to transforming the landscape of drug development.
+78 vs industry average
DTx Pharma, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at DTx Pharma, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Reported emissions
No reported emissions data is available for DTx Pharma, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
DTx Pharma, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for DTx Pharma, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for DTx Pharma, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project